GLP-1 drugs are influencing food M&A, but buyers risk overvaluing health-led assets and underpricing adaptable bakery and ...
EU-funded research reveals how vague food claims, hidden sponsorships, influencers and AI can mislead consumers – and how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results